Nolato AB (publ) Logo

Nolato AB (publ)

NOLA-B.ST

(2.0)
Stock Price

54,65 SEK

6.47% ROA

8.89% ROE

29.06x PER

Market Cap.

14.125.395.645,00 SEK

35.55% DER

2.93% Yield

5.01% NPM

Nolato AB (publ) Stock Analysis

Nolato AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Nolato AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

3 ROE

ROE in an average range (9.35%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (6.86%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 PBV

The stock's PBV ratio (2.63x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (895), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

Nolato AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Nolato AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Nolato AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Nolato AB (publ) Revenue
Year Revenue Growth
2002 2.011.000.000
2003 2.671.000.000 24.71%
2004 2.401.000.000 -11.25%
2005 2.256.000.000 -6.43%
2006 2.702.000.000 16.51%
2007 2.421.000.000 -11.61%
2008 2.824.000.000 14.27%
2009 2.602.000.000 -8.53%
2010 3.375.000.000 22.9%
2011 2.977.000.000 -13.37%
2012 3.874.000.000 23.15%
2013 4.522.000.000 14.33%
2014 4.234.000.000 -6.8%
2015 4.726.000.000 10.41%
2016 4.447.000.000 -6.27%
2017 6.720.000.000 33.82%
2018 8.102.000.000 17.06%
2019 7.919.000.000 -2.31%
2020 9.359.000.000 15.39%
2021 11.610.000.000 19.39%
2022 10.774.000.000 -7.76%
2023 9.360.000.000 -15.11%
2023 9.546.000.000 1.95%
2024 9.756.000.000 2.15%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Nolato AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 248.000.000 100%
2013 211.000.000 -17.54%
2014 227.000.000 7.05%
2015 347.000.000 34.58%
2016 392.000.000 11.48%
2017 495.000.000 20.81%
2018 604.000.000 18.05%
2019 478.000.000 -26.36%
2020 562.000.000 14.95%
2021 751.000.000 25.17%
2022 676.000.000 -11.09%
2023 0 0%
2023 546.000.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Nolato AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 156.000.000
2003 172.000.000 9.3%
2004 134.000.000 -28.36%
2005 135.000.000 0.74%
2006 63.000.000 -114.29%
2007 81.000.000 22.22%
2008 140.000.000 42.14%
2009 132.000.000 -6.06%
2010 160.000.000 17.5%
2011 144.000.000 -11.11%
2012 156.000.000 7.69%
2013 165.000.000 5.45%
2014 162.000.000 -1.85%
2015 170.000.000 4.71%
2016 170.000.000 0%
2017 205.000.000 17.07%
2018 217.000.000 5.53%
2019 231.000.000 6.06%
2020 293.000.000 21.16%
2021 357.000.000 17.93%
2022 389.000.000 8.23%
2023 432.000.000 9.95%
2023 462.000.000 6.49%
2024 468.000.000 1.28%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Nolato AB (publ) EBITDA
Year EBITDA Growth
2002 204.000.000
2003 213.000.000 4.23%
2004 335.000.000 36.42%
2005 341.000.000 1.76%
2006 236.000.000 -44.49%
2007 354.000.000 33.33%
2008 421.000.000 15.91%
2009 343.000.000 -22.74%
2010 408.000.000 15.93%
2011 363.000.000 -12.4%
2012 444.000.000 18.24%
2013 564.000.000 21.28%
2014 633.000.000 10.9%
2015 741.000.000 14.57%
2016 640.000.000 -15.78%
2017 973.000.000 34.22%
2018 1.207.000.000 19.39%
2019 1.254.000.000 3.75%
2020 1.466.000.000 14.46%
2021 1.914.000.000 23.41%
2022 1.473.000.000 -29.94%
2023 492.000.000 -199.39%
2023 1.243.000.000 60.42%
2024 1.528.000.000 18.65%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Nolato AB (publ) Gross Profit
Year Gross Profit Growth
2002 267.000.000
2003 324.000.000 17.59%
2004 395.000.000 17.97%
2005 405.000.000 2.47%
2006 431.000.000 6.03%
2007 539.000.000 20.04%
2008 439.000.000 -22.78%
2009 329.000.000 -33.43%
2010 486.000.000 32.3%
2011 367.000.000 -32.43%
2012 521.000.000 29.56%
2013 654.000.000 20.34%
2014 714.000.000 8.4%
2015 822.000.000 13.14%
2016 714.000.000 -15.13%
2017 1.078.000.000 33.77%
2018 1.257.000.000 14.24%
2019 1.248.000.000 -0.72%
2020 1.506.000.000 17.13%
2021 1.817.000.000 17.12%
2022 1.428.000.000 -27.24%
2023 1.144.000.000 -24.83%
2023 1.336.000.000 14.37%
2024 1.648.000.000 18.93%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Nolato AB (publ) Net Profit
Year Net Profit Growth
2002 60.000.000
2003 35.000.000 -71.43%
2004 130.000.000 73.08%
2005 181.000.000 28.18%
2006 48.000.000 -277.08%
2007 150.000.000 68%
2008 178.000.000 15.73%
2009 123.000.000 -44.72%
2010 187.000.000 34.22%
2011 132.000.000 -41.67%
2012 202.000.000 34.65%
2013 314.000.000 35.67%
2014 364.000.000 13.74%
2015 420.000.000 13.33%
2016 336.000.000 -25%
2017 572.000.000 41.26%
2018 722.000.000 20.78%
2019 703.000.000 -2.7%
2020 806.000.000 12.78%
2021 1.160.000.000 30.52%
2022 697.000.000 -66.43%
2023 276.000.000 -152.54%
2023 435.000.000 36.55%
2024 676.000.000 35.65%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Nolato AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 0
2003 0 0%
2004 1 0%
2005 1 0%
2006 0 0%
2007 1 0%
2008 1 0%
2009 0 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 100%
2014 1 0%
2015 2 0%
2016 1 0%
2017 2 50%
2018 3 0%
2019 3 0%
2020 3 33.33%
2021 4 25%
2022 3 -100%
2023 1 -100%
2023 2 0%
2024 3 50%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Nolato AB (publ) Free Cashflow
Year Free Cashflow Growth
2002 -119.000.000
2003 -99.000.000 -20.2%
2004 231.000.000 142.86%
2005 158.000.000 -46.2%
2006 128.000.000 -23.44%
2007 220.000.000 41.82%
2008 297.000.000 25.93%
2009 136.000.000 -118.38%
2010 231.000.000 41.13%
2011 112.000.000 -106.25%
2012 317.000.000 64.67%
2013 361.000.000 12.19%
2014 126.000.000 -186.51%
2015 286.000.000 55.94%
2016 243.000.000 -17.7%
2017 494.000.000 50.81%
2018 591.000.000 16.41%
2019 800.000.000 26.13%
2020 791.000.000 -1.14%
2021 446.000.000 -77.35%
2022 -49.000.000 1010.2%
2023 280.000.000 117.5%
2023 351.000.000 20.23%
2024 434.000.000 19.12%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Nolato AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2002 0
2003 0 0%
2004 356.000.000 100%
2005 307.000.000 -15.96%
2006 277.000.000 -10.83%
2007 312.000.000 11.22%
2008 451.000.000 30.82%
2009 257.000.000 -75.49%
2010 370.000.000 30.54%
2011 246.000.000 -50.41%
2012 476.000.000 48.32%
2013 512.000.000 7.03%
2014 330.000.000 -55.15%
2015 532.000.000 37.97%
2016 466.000.000 -14.16%
2017 773.000.000 39.72%
2018 1.045.000.000 26.03%
2019 1.160.000.000 9.91%
2020 1.164.000.000 0.34%
2021 1.228.000.000 5.21%
2022 406.000.000 -202.46%
2023 280.000.000 -45%
2023 781.000.000 64.15%
2024 434.000.000 -79.95%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Nolato AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2002 119.000.000
2003 99.000.000 -20.2%
2004 125.000.000 20.8%
2005 149.000.000 16.11%
2006 149.000.000 0%
2007 92.000.000 -61.96%
2008 154.000.000 40.26%
2009 121.000.000 -27.27%
2010 139.000.000 12.95%
2011 134.000.000 -3.73%
2012 159.000.000 15.72%
2013 151.000.000 -5.3%
2014 204.000.000 25.98%
2015 246.000.000 17.07%
2016 223.000.000 -10.31%
2017 279.000.000 20.07%
2018 454.000.000 38.55%
2019 360.000.000 -26.11%
2020 373.000.000 3.49%
2021 782.000.000 52.3%
2022 455.000.000 -71.87%
2023 0 0%
2023 430.000.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Nolato AB (publ) Equity
Year Equity Growth
2002 624.000.000
2003 569.000.000 -9.67%
2004 655.000.000 13.13%
2005 832.000.000 21.27%
2006 789.000.000 -5.45%
2007 881.000.000 10.44%
2008 1.058.000.000 16.73%
2009 1.086.000.000 2.58%
2010 1.179.000.000 7.89%
2011 1.151.000.000 -2.43%
2012 1.205.000.000 4.48%
2013 1.348.000.000 10.61%
2014 1.567.000.000 13.98%
2015 1.759.000.000 10.92%
2016 1.850.000.000 4.92%
2017 2.159.000.000 14.31%
2018 2.592.000.000 16.71%
2019 2.966.000.000 12.61%
2020 3.699.000.000 19.82%
2021 4.768.000.000 22.42%
2022 5.392.000.000 11.57%
2023 5.171.000.000 -4.27%
2023 5.382.000.000 3.92%
2024 5.280.000.000 -1.93%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Nolato AB (publ) Assets
Year Assets Growth
2002 1.895.000.000
2003 1.835.000.000 -3.27%
2004 1.598.000.000 -14.83%
2005 1.668.000.000 4.2%
2006 1.724.000.000 3.25%
2007 1.918.000.000 10.11%
2008 2.126.000.000 9.78%
2009 2.113.000.000 -0.62%
2010 2.350.000.000 10.09%
2011 2.144.000.000 -9.61%
2012 2.634.000.000 18.6%
2013 2.573.000.000 -2.37%
2014 2.914.000.000 11.7%
2015 3.233.000.000 9.87%
2016 3.924.000.000 17.61%
2017 4.752.000.000 17.42%
2018 5.156.000.000 7.84%
2019 6.134.000.000 15.94%
2020 8.684.000.000 29.36%
2021 10.055.000.000 13.64%
2022 10.007.000.000 -0.48%
2023 9.300.000.000 -7.6%
2023 9.924.000.000 6.29%
2024 9.809.000.000 -1.17%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Nolato AB (publ) Liabilities
Year Liabilities Growth
2002 1.271.000.000
2003 1.266.000.000 -0.39%
2004 943.000.000 -34.25%
2005 836.000.000 -12.8%
2006 935.000.000 10.59%
2007 1.037.000.000 9.84%
2008 1.068.000.000 2.9%
2009 1.027.000.000 -3.99%
2010 1.171.000.000 12.3%
2011 993.000.000 -17.93%
2012 1.429.000.000 30.51%
2013 1.225.000.000 -16.65%
2014 1.347.000.000 9.06%
2015 1.474.000.000 8.62%
2016 2.074.000.000 28.93%
2017 2.593.000.000 20.02%
2018 2.564.000.000 -1.13%
2019 3.168.000.000 19.07%
2020 4.985.000.000 36.45%
2021 5.287.000.000 5.71%
2022 4.615.000.000 -14.56%
2023 4.129.000.000 -11.77%
2023 4.542.000.000 9.09%
2024 4.529.000.000 -0.29%

Nolato AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
35.17
Net Income per Share
1.76
Price to Earning Ratio
29.06x
Price To Sales Ratio
1.49x
POCF Ratio
13.33
PFCF Ratio
23.16
Price to Book Ratio
2.61
EV to Sales
1.63
EV Over EBITDA
12.92
EV to Operating CashFlow
14.91
EV to FreeCashFlow
25.33
Earnings Yield
0.03
FreeCashFlow Yield
0.04
Market Cap
14,13 Bil.
Enterprise Value
15,45 Bil.
Graham Number
27.89
Graham NetNet
-6.94

Income Statement Metrics

Net Income per Share
1.76
Income Quality
2.18
ROE
0.09
Return On Assets
0.05
Return On Capital Employed
0.1
Net Income per EBT
0.7
EBT Per Ebit
0.9
Ebit per Revenue
0.08
Effective Tax Rate
0.3

Margins

Sales, General, & Administrative to Revenue
0.05
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.15
Operating Profit Margin
0.08
Pretax Profit Margin
0.07
Net Profit Margin
0.05

Dividends

Dividend Yield
0.03
Dividend Yield %
2.93
Payout Ratio
0
Dividend Per Share
1.5

Operating Metrics

Operating Cashflow per Share
3.85
Free CashFlow per Share
2.26
Capex to Operating CashFlow
0.41
Capex to Revenue
0.04
Capex to Depreciation
0.71
Return on Invested Capital
0.07
Return on Tangible Assets
0.06
Days Sales Outstanding
66.04
Days Payables Outstanding
0
Days of Inventory on Hand
54.91
Receivables Turnover
5.53
Payables Turnover
0
Inventory Turnover
6.65
Capex per Share
1.58

Balance Sheet

Cash per Share
2,86
Book Value per Share
19,60
Tangible Book Value per Share
10.42
Shareholders Equity per Share
19.6
Interest Debt per Share
7.18
Debt to Equity
0.36
Debt to Assets
0.19
Net Debt to EBITDA
1.11
Current Ratio
1.82
Tangible Asset Value
2,81 Bil.
Net Current Asset Value
-0,42 Bil.
Invested Capital
7530000000
Working Capital
1,85 Bil.
Intangibles to Total Assets
0.25
Average Receivables
1,72 Bil.
Average Payables
0,00 Bil.
Average Inventory
1192500000
Debt to Market Cap
0.13

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Nolato AB (publ) Dividends
Year Dividends Growth
2000 2
2001 2 0%
2003 1 0%
2004 1 0%
2005 2 100%
2006 2 50%
2007 2 0%
2008 3 33.33%
2009 3 -50%
2010 3 33.33%
2011 3 0%
2012 2 -50%
2013 3 0%
2014 4 50%
2015 9 50%
2016 10 20%
2017 11 0%
2018 13 16.67%
2019 14 14.29%
2020 140 90%
2021 16 -775%
2022 2 -1500%
2023 2 0%
2024 2 0%

Nolato AB (publ) Profile

About Nolato AB (publ)

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, and other industrial sectors in North America, Sweden, Asia, and other Europe region. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; manufactures pipette tips, deep-well plates, microtubes, and PCR products; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic and customized production solutions. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating products; automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for food processing equipment, such as coffee machines and blenders. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was incorporated in 1938 and is headquartered in Torekov, Sweden.

CEO
Mr. Christer Wahlquist MBA, M
Employee
5.956
Address
NolatovAegen 32
Torekov, 269 78

Nolato AB (publ) Executives & BODs

Nolato AB (publ) Executives & BODs
# Name Age
1 Anders Willman
Managing Director of Nolato Polymer
70
2 Mr. Mats Håkansson
Group Corporate Communication Manager
70
3 Mr. Johan Iveberg
President of Medical Solutions
70
4 Mr. Glenn Svedberg
Group Sustainability Director & Technology Director
70
5 Mr. Christer Wahlquist MBA, ME
President, Chief Executive Officer & Interim President of Industrial Solutions
70
6 Mr. Per-Ola Holmstrom MBA
Deputy Chief Executive Officer & Chief Financial Officer
70
7 Mr. Dan Wong
Managing Director of Nolato Lovepac Converting
70
8 Thomas Hofflander
Managing Director of Nolato Beijing Medical & Nolato Beijing
70
9 Olof Pettersson
Managing Director of Nolato Gota & Nolato Plastteknik
70
10 Henrik Enoksson
Managing Director of Nolato Lövepac
70

Nolato AB (publ) Competitors

HEXPOL AB (publ) Logo
HEXPOL AB (publ)

HPOL-B.ST

(3.5)
Trelleborg AB (publ) Logo
Trelleborg AB (publ)

TREL-B.ST

(2.0)
Indutrade AB (publ) Logo
Indutrade AB (publ)

INDT.ST

(3.5)
Vitrolife AB (publ) Logo
Vitrolife AB (publ)

VITR.ST

(3.2)
Mycronic AB (publ) Logo
Mycronic AB (publ)

MYCR.ST

(2.8)